 2. Clinically significant, unrelated systemic illness serious infections or significant cardiac, pulmonary, hepatic or other organ dysfunction which in the judgment of the Principal Investigator or Chairpersons would compromise the patients ability to tolerate this study or is likely to interfere with the study procedures or results 